1. Home
  2. ABSI vs EFC Comparison

ABSI vs EFC Comparison

Compare ABSI & EFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Absci Corporation

ABSI

Absci Corporation

N/A

Current Price

$8.40

Market Cap

1.4B

Sector

Health Care

ML Signal

N/A

EFC

Ellington Financial Inc.

N/A

Current Price

$10.83

Market Cap

1.5B

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ABSI
EFC
Founded
2011
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.5B
IPO Year
2021
2007

Fundamental Metrics

Financial Performance
Metric
ABSI
EFC
Price
$8.40
$10.83
Analyst Decision
Strong Buy
Buy
Analyst Count
12
8
Target Price
★ $15.09
$14.43
AVG Volume (30 Days)
★ 4.2M
1.8M
Earning Date
11-12-2026
11-04-2026
Dividend Yield
N/A
★ 14.61%
EPS Growth
★ 10.64
N/A
EPS
N/A
★ 1.51
Revenue
★ $4,534,000.00
N/A
Revenue This Year
N/A
$106.12
Revenue Next Year
$37.25
$12.80
P/E Ratio
★ N/A
$7.07
Revenue Growth
N/A
★ N/A
52 Week Low
$2.24
$10.63
52 Week High
$12.54
$14.12

Technical Indicators

Market Signals
Indicator
ABSI
EFC
Relative Strength Index (RSI) 43.96 36.39
Support Level $7.79 N/A
Resistance Level $11.94 $12.02
Average True Range (ATR) 1.03 0.31
MACD -0.30 -0.05
Stochastic Oscillator 24.61 15.65

Price Performance

Historical Comparison
ABSI
EFC

About ABSI Absci Corporation

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.

About EFC Ellington Financial Inc.

Ellington Financial Inc is a specialty finance company. Its primary investment objective is to generate attractive, risk-adjusted total returns for its shareholders by making investments. The company has two reportable segments; The Investment Portfolio Segment is focused on investing in a diverse array of financial assets, including residential and commercial mortgage loans, residential mortgage-backed securities, non-mortgage- and mortgage-related derivatives, debt and equity investments in loan origination companies, and other strategic investments, and The Longbridge Segment is focused on the origination and servicing of reverse mortgage loans. It acquires reverse mortgage loans both through its origination activities and through secondary market purchases.

Share on Social Networks: